BioLineRx Ltd. is a biopharmaceutical company that focuses on oncology and has developed several treatments for different types of cancers. The company has completed clinical trials for Motixafortide, a peptide to treat various cancers, including pancreatic cancer, respiratory viral infections, and acute myeloid leukemia. Additionally, BioLineRx Ltd. has collaboration agreements with MSD and MD Anderson Cancer Center, as well as a licensing arrangement with Perrigo Company plc.